Right now, the HALT Study is underway to provide the substantial evidence of effectiveness necessary for the full FDA approval of Felycin-CA1 (referred to as TRIV202 in HALT) for the management of ...
It's time now for our science news roundup from Short Wave, NPR's science podcast. I'm joined here in studio by the show's two hosts, Regina Barber and Emily Kwong. Hi, y'all. EMILY KWONG, BYLINE: Hi, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback